Clinical Trial Update: A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 dose-escalation trial update for FF-10832 in advanced solid tumors, including biliary tract cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• FF-10832

Snippet

Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. | Conditions: Advanced Solid Tumors, Biliary Tract Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING